本文提要
愿景:距离消除病毒性肝炎只剩十年!
参考文献:
[1] Baruch S. Blumberg – Facts. NobelPrize.org. Nobel Media AB 2020. Available via https://www.nobelprize.org/prizes/medicine/1976/blumberg/facts/ Accessed on 2020-07-28.
[2] World Health Organization. World Hepatitis Day. Available via https://www.who.int/zh/campaigns/world-hepatitis-day Accessed on 2020-07-28.
[3] World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Geneva, Switzerland: World Health Organization. Available via https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ Accessed 2020-07-28.
[4] World Health Organization. Progress report on HIV, viral hepatitis and sexually transmitted infections 2019. Accountability for the global health sector strategies, 2016–2021. Geneva, Switzerland: World Health Organization. https://www.who.int/hiv/strategy2016-2021/progress-report-2019/en/ Accessed 2020-07-28.
[5] Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383-403. doi:10.1016/S2468-1253(18)30056-6.
[6] Dusheiko G, Agarwal K. Delineating the global challenges of hepatitis B virus infection. Lancet Gastroenterol Hepatol. 2018;3(6):372-373. doi:10.1016/S2468-1253(18)30093-1.
[7] Cooke GS, Andrieux-Meyer I, Applegate TL, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission [published correction appears in Lancet Gastroenterol Hepatol. 2019 May;4(5):e4]. Lancet Gastroenterol Hepatol. 2019;4(2):135-184. doi:10.1016/S2468-1253(18)30270-X.
[8] Brierley R. Elimination of viral hepatitis by 2030: ambitious, but achievable. Lancet Gastroenterol Hepatol. 2019;4(2):88-89. doi:10.1016/S2468-1253(18)30420-5.
[9] Peck R, Wingrove C, Ninburg M. Civil society's critical role in the elimination of viral hepatitis. Lancet Gastroenterol Hepatol. 2019;4(2):90-91. doi:10.1016/S2468-1253(18)30381-9.
[10] Arora S. Project ECHO: democratising knowledge for the elimination of viral hepatitis. Lancet Gastroenterol Hepatol. 2019;4(2):91-93. doi:10.1016/S2468-1253(18)30390-X.
[11] Cunningham C. Accelerating the elimination of viral hepatitis for Indigenous peoples. Lancet Gastroenterol Hepatol. 2019;4(2):93-94. doi:10.1016/S2468-1253(18)30412-6.
[12] Sarin SK, Kumar M, Eslam M, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5(2):167-228. doi:10.1016/S2468-1253(19)30342-5.
[13] Singh PK. Sustain, accelerate, innovate: the burden of liver disease and way forward in the WHO South-East Asia region. Lancet Gastroenterol Hepatol. 2020;5(2):100-102. doi:10.1016/S2468-1253(19)30318-8.
[14] Kasai T. Time to act to make elimination of viral hepatitis a reality. Lancet Gastroenterol Hepatol. 2020;5(2):102-103. doi:10.1016/S2468-1253(19)30303-6.
[15] Wong GL, Wong VW. How many deaths are caused by non-alcoholic fatty liver disease in the Asia-Pacific region?. Lancet Gastroenterol Hepatol. 2020;5(2):103-105. doi:10.1016/S2468-1253(19)30338-3.
[16] Jiang H, Room R, Waleewong O, Hao W. Restricting alcohol consumption to reduce liver disease in the Asia-Pacific region. Lancet Gastroenterol Hepatol. 2020;5(2):105-107. doi:10.1016/S2468-1253(19)30322-X.
[17] Wingrove C, Wang S, Ninburg M, Agustian E, Lee D. Communities living with hepatitis must be central to the response to liver diseases in the Asia-Pacific region. Lancet Gastroenterol Hepatol. 2020;5(2):107-109. doi:10.1016/S2468-1253(19)30360-7.
[18] Schmelzer J, Dugan E, Blach S, et al. Global prevalence of hepatitis C virus in children in 2018: a modelling study. Lancet Gastroenterol Hepatol. 2020;5(4):374-392. doi:10.1016/S2468-1253(19)30385-1.
[19] Lens S, Lazarus JV. The paediatric population: the forgotten element to eliminating hepatitis C virus. Lancet Gastroenterol Hepatol. 2020;5(4):334-335. doi:10.1016/S2468-1253(19)30405-4.
[20] Palayew A, Razavi H, Hutchinson SJ, et al. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C? Lancet Gastroenterol Hepatol. Published Online July 27, 2020. doi: 10.1016/ S2468-1253(20)30011-X.
[21] Scott N, Kuschel C, Pedrana A, et al. A model of the economic benefits of global hepatitis C elimination: an investment case. Lancet Gastroenterol Hepatol. Published Online July 27, 2020. doi: 10.1016/ S2468-1253(20)30008-X.
[22] Pedrana A, Howell J, Scott N, et al. Global hepatitis C elimination: an investment framework. Lancet Gastroenterol Hepatol. Published Online July 27, 2020. doi:10.1016/ S2468-1253(20)30010-8.
本文首发:医学界消化肝病频道
本文作者:Baleno
责任编辑:Mary
版权申明
联系客服